Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes

American Journal of Cardiology

Volumn 99, Issue 12, 2007, Pages 1637-1642

  Testa, Luca ^a   Zoccai, Giuseppe Biondi ^b   Porto, Italo ^c   Trotta, Graziana ^c   Agostoni, Pierfrancesco ^d   Andreotti, Felicita ^c   Crea, Filippo ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEATH; FOLLOW UP; HEART INFARCTION; HUMAN; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

ANTICOAGULANTS; ASPIRIN; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SYNDROME; TICLOPIDINE; WARFARIN;

EID: 34249895883     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.052     Document Type: Article

References (31)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
2. COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
3. Anand S.S., and Yusuf S. Oral anticoagulants in patients with coronary artery disease: a meta analysis. JAMA 282 (1999) 2058-2067
4. Anand S.S., and Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol 41 suppl (2003) S62-S69
5. Andreotti F., Testa L., Biondi-Zoccai G., and Crea F. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: a comprehensive meta-analysis of 25307 patients. Eur Heart J 27 (2006) 519-526
6. Patsopoulos N.A., Analatos A.A., and Ioannidis J.P.A. Relative citation impact of various study designs in health sciences. JAMA 293 (2005) 2362-2366
7. Song F., Altman D., Glenny A.-M., and Deeks J.J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysis. BMJ 326 (2003) 472
8. Biondi Zoccai G.G., Agostoni P., Abbate A., Testa L., and Burzotta F. A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 34 (2005) 224-225
9. Cochrane Reviewers' Handbook 4.1.3. In: Clarke M., and Oxman A.D. (Eds). The Cochrane Library (2001), Update Software, Oxford, UK Issue 3, Updated quarterly
10. Higgins J.P.T., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
11. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
12. Biondi-Zoccai G.G.L., Agostoni P., Abbate A., Testa L., Burzotta F., Lotrionte M., Crea F., Biasucci M., Vetrovec G.W., and Colombo A. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trias. Int J Cardiol 100 (2005) 119-123
13. Cohen M., Adams P.C., Hawkins L., Bach M., and Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non Q wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes study group). Am J Cardiol 66 (1990) 1287-1292
14. Cohen M., Adams P.C., Parry G., Xiong J., Chamberlain D., Wieczorek I., Fox K.A., Chesebro J.H., Strain J., and Keller C. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in non prior aspirin users. Primary end points analysis from the ATACS Trial. Circulation 89 (1994) 81-88
15. Williams M.J.A., Morison I.M., Parker J.H., and Stewart R.A.H. Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study. J Am Coll Cardiol 30 (1997) 364-369
16. Anand S.S., Yusuf S., Pogue J., Weitz J.I., Flather M., and OASIS Pilot Study Investigators. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction. Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilot study results. Circulation 98 (1998) 1064-1070
17. Huynh T., Theroux P., Bogaty P., Nasmith J., and Solymoss S. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 103 (2001) 3069-3074
18. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Effects of long term, moderate intensity oral anticoagulation in addition to aspirin in unstable angina. J Am Coll Cardiol 37 (2001) 475-484
19. van Es R.F., Jonker J.J., Verheugt F.W., Deckers J.W., and Grobbee D.E. Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 360 (2002) 109-113
20. Brouwer M.A., van den Bergh P.J., Aengevaeren W.R., Veen G., Luijten H.E., Hertzberger D.P., van Boven A.D., Vromans R., Uijen G., and Verheugt F. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the APRICOT 2 trial. Circulation 106 (2002) 659-665
21. Hurlen M., Abdelnoor M., Smith P., Erikssen J., and Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347 (2002) 969-974
22. Zibaeenezhad M.J., Mowla A., and Sorbi M.H. Warfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot study. Angiology 55 (2004) 17-20
23. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
24. Sabatine M.S., Cannon C.P., Gibson C.M., Lopez-Sendon J.L., Montalescot G., Theroux P., Claeys M.J., Cools F., Hill K.A., Skene A.M., McCabe C.H., Braunwald E., and CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST segment elevation. N Engl J Med 352 (2005) 1179-1189
25. CAPRIE Steering Committee. A randomised, blinded trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet 348 (1996) 1329-1339
26. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black A.R., Boden W.E., Cacoub P., Cohen F.A., Creager M.A., Easton S.D., Flatner M.D., Hapfner S.M., et al. Clopidogrel plus aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
27. Mehta S.R., Yusuf S., Peters R.J., Bertrand M., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhad F., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
28. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Developed in Collaboration With the Canadian Cardiovascular Society. Available at www.americanheart.org. Accessed October 2006.
29. ACC/AHA. Guidelines for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 36 (2000) 970-1062
30. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., Schomig A., and ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
31. Zhou Z., Rahme E., and Pilote L. Are statins created equal?. Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J 151 (2006) 273-281